Phase 2CompletedAge-related condition
Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
- Sponsor
- Levicept (Industry)
- Enrollment
- 518 enrolled
- Conditions
- Pain; Osteo Arthritis Knee; Knee Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases
- Interventions
- LEVI-04; Placebo
- Ages
- adults, older adults
- Registry
- NCT05618782
Full record on ClinicalTrials.gov
From the registry
This is a phase 2, randomized, double-blind, placebo-controlled trial of multiple doses and multiple administrations of LEVI-04 for the treatment of pain due to osteoarthritis of the knee.
Primary outcomes
- Least Squares Mean Change From Baseline in WOMAC Pain
History
Last registry update
Results first posted
Primary completion
Registered
Started